EICHORCondition: Advanced Solid Tumor · Sponsor: T3 Pharmaceuticals AG
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a first in human, phase I/II open-label, dose-finding, safety, and proof-of-concept clinical trial of T3P-Y058-739, a genetically-modified, live attenuated strain of the bacterium Yersinia enterocolitica, in patients with advanced solid tumors.
This description comes directly from the study's public registry record.
Chief Medical Officer (CMO) · +4178.3060080 · T3P1001@t3pharma.com
Head Clinical Operations · +4179.355.9741
Always discuss trial participation with your own doctor first.
| Clinica Universidad de Navarra | Pamplona, Navarre, Spain | Recruiting |
| Vall d'Hebron Institute of Oncology | Barcelona, Spain | Recruiting |
| Institut Catala D'oncologia | L'Hospitalet de Llobregat, Spain | Recruiting |
| Clinica Universidad de Navarra | Madrid, Spain | Recruiting |
| Hospital Universitario 12 De Octubre | Madrid, Spain | Recruiting |
| Hospital Universitario La Paz | Madrid, Spain | Recruiting |
| START Madrid-CIOCC Hospital Univ. HM Sanchinarro | Madrid, Spain | Recruiting |
| Hospital Clínico Universitario de Valencia (INCLIVA) | Valencia, Spain | Recruiting |
| University Hospital Bern (Inselspital) | Bern, Switzerland | Recruiting |
| Centre Hospitalier Universitaire Vaudois Lausanne (CHUV) | Lausanne, Switzerland | Recruiting |
| University Hospital of Zürich (Universitätsspital Zürich) | Zurich, Switzerland | Recruiting |
| Cancer Research UK Clinical trials; Unit Partner in CaCTUS- Cancer clinical trials Unit Scotland; Beatson West of Scotland Cancer Centre | Glasgow, United Kingdom | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05120596